Latest Breaking News On - Alexandran nowbar - Page 1 : comparemela.com

Elixir Medical s Late-Breaking 12-Month Data Demonstrate Significant Improvement in Safety and Effectiveness of World s First Site-Specific Antithrombotic Therapeutic Compared to DES

DESyne BDS Plus system with site-specific antithrombotic therapeutic (TRx) significantly reduced the risk of TLF versus conventional drug-eluting stent through 12-months

New zealandSao pauloFrance generalUnited statesAlexandran nowbarJamesp howardMichael foleyKui hongMotasim sirhanXiaoqing liLiza chackoDarrelp francisDina mahdiSayan senAlexandre abizaidGraham cole

Elixir Medical Corporation: EuroPCR 2024: Elixir Medical s Late-Breaking 12-Month Data Demonstrate Significant Improvement in Safety and Effectiveness of World s First Site-Specific Antithrombotic Therapeutic Compared to DES

Elixir Medical Corporation: EuroPCR 2024: Elixir Medical s Late-Breaking 12-Month Data Demonstrate Significant Improvement in Safety and Effectiveness of World s First Site-Specific Antithrombotic Therapeutic Compared to DES
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

France generalSao pauloNew zealandUnited statesLiza chackoAlexandre abizaidYuhao suKui hongChristopher rajkumarXiaoqing liJamesp howardRasha al lameeSayan senEmma yangYousif ahmadGraham cole

Six-Month Clinical Data from DESyne BDS Plus Randomized Controlled Trial (RCT) Presented at TCT 2023 Shines Spotlight on Safety, Effectiveness of World s First Site-Specific Antithrombotic Drug Therapy

Positive six-month clinical data were announced by Elixir Medical during the Transcatheter Cardiovascular Therapeutics (TCT) conference, TCT 2023, in San Francisco, CA today. The DESyne BDS Plus Randomized Controlled Trial (RCT) evaluated DESyne BDS Plus, the world’s first triple drug-eluting coronary implant with site-specific delivery of antithrombotic drugs versus a second-generation, durable polymer drug-eluting stent (DES).

San franciscoUnited statesNew zealandYuhao suJamesp howardStefan verheyeKui hongGraham coleLiza chackoYousif ahmadChristopher kaneDina mahdiRasha al lameeSayan senChristopher rajkumarAlexandran nowbar